The Kennedy Institute partners with industry, business, and other academic institutions to drive research leading to transformative therapies for inflammatory and degenerative diseases.
Our academic expertise strengthens scientific discovery for health-related challenges, and we provide access to state-of-the-art core technology platforms, as well as access to patient cohorts.
These case studies showcase our research collaborations and the spin-out work that is helping to create impact for health in wider society.
The Kennedy Institute joined a Roche-coordinated research network to better understand the role of fibroblasts in Inflammatory Bowel Disease (IBD) and ultimately develop treatments that target its underlying causes
The Kennedy Institute is conducting ground-breaking research into the molecular pathways of osteoarthritis (OA) as part a consortium with academic, industry and charity partners.